Dr Reddy’s recalls over 8,000 bottles of generic drug in US due to packaging error
时间:2024-06-28 23:17:32 阅读(143)
Dr Reddy’s Laboratories is recalling over 8,000 bottles of a generic medication used to prevent rejection of a transplanted organ from the US market due to a packaging error, according to the US Food & Drug Administration.
The Hyderabad-based drug major is recalling 8,280 bottles of Tacrolimus capsules from the US market for “presence of foreign tablets/capsules” in the affected lot.
The affected lot was produced at Dr Reddy’s Bachupally-based plant near Hyderabad.
New Jersey-based Dr Reddy’s Laboratories, Inc has initiated the nationwide (US) Class II recall on December 15, 2023.
As per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Dr Reddy’s had recalled 4,000 bottles of the same drug in March last year as well. The company had initiated the recall on February 8, 2023.
猜你喜欢
- Bajaj Consumer board approves Rs 81 crore buyback plan, shares jump 3%; check price, size details
- Dollar weakens on dovish Fed outlook; What to expect next-
- Delhi-Noida-Greater Noida Corridor- NMRC approves Sector-142 to Botanical Garden Metro section for enhancing connectivity – Check details
- Share Market Highlights- Nifty settles above19540, Sensex above 65630; Bank Nifty adds over 240 points
- Axis Bank Rating- Buy - Committed to compete with banks
- Domestic paper industry to witness ~7-10% revenue contraction in FY24 amid 2-5% shrink in volume growth, pressure on realisations
- Asian stocks struggle as traders mull hawkish US Fed comments, US-China ties; July US employment data eyed
- Assembly Elections 2023 - BJP supporters go on celebration spree as party leads in MP, Rajasthan and Chhattisgarh; Congress celebrates in Telangana – See Photos
- Share Market Highlights- Nifty settles under 19400, Sensex ends flat; Adani Ent jumps 2%, metal stocks shine